| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Gastaut H, Ferrer S, Cast... |
Action de la diéthylamide de l'acide d-lysergique (LSD 25) sur les fon... |
Confinia Neurol. |
1953 |
| Eichenberger E, Friolet B |
Pharmakologische Beeinflussung des Pyrogen- und LSD-Fiebers des Kaninc... |
Helvet. physiol. et ... |
1957 |
| Haley TJ |
Pharmacological actions from intracerebral drug injections |
Psychotropic drugs |
1957 |
| Ruiz C |
Las psicosis experimentales. Estudio comparativo entre las del LSD-25... |
Frontis |
1958 |
| Tabachnick A II, |
Inhibition of cholinesterase hydrolysis of dihydromurexine by lysergic... |
Nature |
1958 |
| Stähelin H, Taeschler M |
Beitrag zur Differenzierung der Fieberwirkung von Lipopolysaccharid-Py... |
Helvet.physiol.pharm... |
1959 |
| Gujral ML, Dhawan BN |
Effects of drugs on LSD-25 induced pyrexia in rabbits. |
Indian J.Physiol.Pha... |
1959 |
| Dhawan BN |
Effect of drugs on LSD-25 induced pyrexia in rabbits. |
Arch.internat.de pha... |
1959 |
| J Delay, P Pichot, T Lemp... |
Effet thérapeutique de la Psilocybine sur une névrose compulsive |
Ann. Méd. Psychol. |
1959 |
| Jovanovic D, Kandic B, Kr... |
Prilog ispitivanju dejstva LSD-25 u eksperimentu na psima |
Vojnosanit. Pregl. |
1960 |
| Dhawan BN |
Blockade of LSD-25 pyrexia by morphine |
Arch. internat. phar... |
1960 |
| Dhawan BN, Gupta GP |
Some further observations on LSD-25 morphine antagonism |
Indian J.Physiol. Ph... |
1960 |
| Bradley CA, Miya TS, Yim ... |
The Effect of Certain Psychopharmacologic Agents on Liver and Brain Su... |
J.Neuropsychiat. |
1961 |
| DELAHUNT CS, O'CONNOR RA,... |
Toxic retinopathy following prolonged treatment with dl-p-trifluoromet... |
Toxicol Appl Pharmac... |
1963 |
| ROSZKOWSKI AP, KELLEY NM |
A rapid method for assessing drug inhibition of feeding behavior |
J Pharmacol Exp Ther... |
1963 |
| Venulet J, Desperak-Nacia... |
Liver function and pyrexia caused by a pyrogen from Escherichia coli, ... |
J. Pharm. Pharmacol. |
1966 |
| Jaju BP, Srimal RC, Dhawa... |
Effect of lysergic acid diethylamide (LSD25) on morphine induced brady... |
Jap. J. Pharmacol. |
1967 |
| Wilson J G |
Present Status of Drugs as Teratogens in Man. |
Teratology |
1973 |
| Bapna JS, Dandiya PC, Kul... |
Dissociation of excitatory and hyperpyrexic effects of LSD in rats tre... |
Jap. J. Pharmacol. |
1973 |
| Freedman DX, Boggan WO |
Brain Serotonin Metabolism After Tolerance Dosage of LSD |
Advances in Biochemi... |
1974 |
| Trube-Becker E |
Drogenabusus mit Todesfolge |
Med. Klin. |
1975 |
| Greenblatt DJ, Allen MD, ... |
Accidental Poisoning with Psychotropic Drugs in Children. |
Am.J.Dis.Child. |
1976 |
| DiMaio VJ, Garriott JC |
Intravenous abuse of propylhexedrine |
J Forensic Sci |
1977 |
| Winter JC |
LSD-Induced Stimulus Control: A Comparison of SCH12,679, Fenfluramine,... |
Psychopharmacology |
1978 |
| Martin WR, Vaupel DB, Noz... |
The Identification Of LSD-like Hallucinogens Using The Chronic Spinal ... |
Drug and Alcohol Dep... |
1978 |
| Nozaki M, Vaupel DB, Brig... |
A Pharmacological Comparison Of 3-methoxy-4,5-methylenedioxyamphetamin... |
Drug and Alcohol Dep... |
1978 |
| Rappolt RT, Gay G, Inaba ... |
Use of Inderal (Propranolol-Ayerst) in 1-a (Early Stimulative) and 1-b... |
Clin.Toxicol. |
1978 |
| Otis LS, Pryor GT, Marqui... |
Preclinical Identification Of Hallucinogenic Compounds |
Pharmacology of Hall... |
1978 |
| Fuller RW, Meyers DB, Gib... |
Depletion of brain serotonin by chronic administration of p-chloramphe... |
Toxicol Appl Pharmac... |
1979 |
| Samanin R, Mennini T, Fer... |
m-Chlorophenylpiperazine: A Central Serotonin Agonist Causing Powerful... |
Naunyn-Schmiedeberg'... |
1979 |
| Anderson RJ, Garza HR, Ga... |
Intravenous prophylhexedrine (Benzedrex) abuse and sudden death |
Am J Med |
1979 |
| Anderson RJ, Garza HR, Ga... |
Intravenous prophylhexedrine (Benzedrex) abuse and sudden death |
Am J Med |
1979 |
| Editorial |
Wie evoziert das LSD: Halluzinationen und Träume? |
Praxis-Kurier |
1980 |
| Teal JJ, Holtzman SG |
Discriminative Stimulus Effects of Cyclazocine in the Rat |
J.Pharmacol Exp.Ther... |
1980 |
| Ruffig DM, Domino EF |
Effects of Selected Opioid Agonists and Antagonists on DMT- and LSD-25... |
Psychopharmacology |
1981 |
| Vaupel DB, Morton EC |
Anorexia and Hyperphagia Produced by Five Pharmacologic Classes of Hal... |
Pharmacology, Bioche... |
1982 |
| Davis FT, Brewster ME |
A Fatality Involving U4EuH, a Cyclic Derivative of Phenylpropanolamine |
Journal of Forensic ... |
1988 |
| Crisp T, Stafinsky JL, Bo... |
The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA... |
Pharmacol Biochem Be... |
1989 |
| Klein RFX, Sperling AR, C... |
The Stereoisomers of 4-Methylaminorex |
Journal of Forensic ... |
1989 |
| Glennon RA, Misenheimer B |
Stimulus properties of a new designer drug: 4-methylaminorex ('U4Euh') |
Pharmacol Biochem Be... |
1990 |
| Mansbach RS, Sannerud CA,... |
Intravenous self-administration of 4-methylaminorex in primates |
Drug Alcohol Depend |
1990 |
| Bilsky EJ, Hubbell CL, De... |
MDMA produces a conditioned place preference and elicits ejaculation i... |
Pharmacol Biochem Be... |
1991 |
| Chadwick IS, Curry PD, Li... |
Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associat... |
J R Soc Med |
1991 |
| Pender ES, Parks BR |
Toxicity with dextromethorphan-containing preparations: a literature r... |
Pediatr Emerg Care |
1991 |
| Hanson GR, Bunker CF, Joh... |
Response of monoaminergic and neuropeptide systems to 4-methylaminorex... |
Eur J Pharmacol |
1992 |
| Young R |
Aminorex produces stimulus effects similar to amphetamine and unlike t... |
Pharmacol Biochem Be... |
1992 |
| Screaton GR, Singer M, Ca... |
Hyperpyrexia and rhabdomyolysis after MDMA ('ecstasy') abuse |
Lancet |
1992 |
| Cardier MA, Clarke JA |
Ecstasy and Whizz at a rave resulting in a major burn plus complicatio... |
Burns |
1993 |
| Rothwell PM, Grant R |
Cerebral venous sinus thrombosis induced by 'ecstasy' |
J Neurol Neurosurg P... |
1993 |
| Cadier MA, Clarke JA |
Ecstasy and Whizz at a rave resulting in a major burn plus complicatio... |
Burns |
1993 |
| Forrest ARW, Galloway JH,... |
A fatal overdose with 3,4-methylenedioxyamphetamine derivatives |
Forensic Sci Int |
1994 |
| McCoy EP, Renfrew C, John... |
Malignant hyperpyrexia in an MDMA ('Ecstasy') abuser |
Ulster Med J |
1994 |
| Henderson GL, Harkey MR, ... |
Metabolism of 4-methylaminorex ('EU4EA') in the rat |
J Anal Toxicol |
1995 |
| Cerruti C, Sheng P, Laden... |
Involvement of oxidative and L-arginine-NO pathways in the neurotoxici... |
Clin Exp Pharmacol P... |
1995 |
| Squier MV, Jalloh S, Hilt... |
Death after ecstasy ingestion: neuropathological findings |
J Neurol Neurosurg P... |
1995 |
| McCauley JC |
Deaths attributed to an 'ecstasy' overdose |
Med J Aust |
1996 |
| Dowsett RP |
Deaths attributed to 'ecstasy' overdose |
Med J Aust |
1996 |
| Matthai SM, Davidson DC, ... |
Cerebral oedema after ingestion of MDMA ('ecstasy') and unrestricted i... |
BMJ |
1996 |
| Miller DB, O'Callaghan JP |
Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Interac... |
Ann N Y Acad Sci |
1996 |
| Mallick A, Bodenham AR |
MDMA induced hyperthermia: a survivor with an initial body temperature... |
J Accid Emerg Med |
1997 |
| Zheng Y, Russell B, Schmi... |
The effects of aminorex and related compounds on brain monoamines and ... |
J Pharm Pharmacol |
1997 |
| Williams A, Unwin R |
Prolonged elevation of serum creatine kinase (CK) without renal failur... |
Nephrol Dial Transpl... |
1997 |
| Box SA, Prescott LF, Free... |
Hyponatraemia at a rave |
Postgrad Med J |
1997 |
| Tsatsakis AM, Michalodimi... |
MDEA related death in Crete: a case report and literature review |
Vet Hum Toxicol |
1997 |
| Lerner AG |
Naltrexone treatment of hallucinogen persisting perception disorder |
Am J Psychiatry |
1997 |
| Gillman PK |
Ecstasy, serotonin syndrome and the treatment of hyperpyrexia |
Med J Aust |
1997 |
| Paronis CA, Woods JH |
Ventilation in morphine-maintained rhesus monkeys I: Effects of naltre... |
J Pharmacol Exp Ther |
1997 |
| Helsley S, Filipink RA, B... |
The effects of sigma, PCP, and opiate receptor ligands in rats trained... |
Pharmacol Biochem Be... |
1998 |
| Decker MW, Bannon AW, Buc... |
Antinociceptive effects of the novel neuronal nicotinic acetylcholine ... |
Eur J Pharmacol |
1998 |
| Gerak LR, Brandt MR, Fran... |
Studies on benzodiazepines and opioids administered alone and in combi... |
Psychopharmacology (... |
1998 |
| Perrine DM |
Hallucinogens and Obsessive-Compulsive Disorder |
Am J Psychiatry |
1999 |
| Hanson GR, Jensen M, John... |
Distinct features of seizures induced by cocaine and amphetamine analo... |
Eur J Pharmacol |
1999 |
| Ito K |
[Studies on the alkaloids of Erythrina plants] |
Yakugaku Zasshi |
1999 |
| Jayanthi S, Ladenheim B, ... |
Overexpression of human copper/zinc superoxide dismutase in transgenic... |
Neuroscience |
1999 |
| Ferrie R, Loveland RC |
Bilateral gluteal compartment syndrome after 'ecstasy' hyperpyrexia |
J R Soc Med |
2000 |
| Boyer EW, Quang L, Woolf ... |
Dextromethorphan and Ecstasy Pills |
JAMA |
2001 |
| Sinclair JD |
Evidence about the use of naltrexone and for different ways of using i... |
Alcohol Alcohol |
2001 |
| Heinälä P, Alho H, Kiianm... |
Targeted use of naltrexone without prior detoxification in the treatme... |
J Clin Psychopharmac... |
2001 |
| Rothman RB, Baumann MH, D... |
Amphetamine-type central nervous system stimulants release norepinephr... |
Synapse |
2001 |
| Kalant, H |
The pharmacology and toxicology of 'ecstasy' (MDMA) and related drugs |
Canadian Medical Ass... |
2001 |
| Nichols CD, Sanders-Bush ... |
Serotonin Receptor Signaling and Hallucinogenic Drug Action |
The Heffter Review o... |
2001 |
| Kraemer T, Maurer HH |
Toxicokinetics of amphetamines: metabolism and toxicokinetic data of d... |
Ther Drug Monit |
2002 |
| Vastag B |
What should the public be told about the risks of Ecstasy? (3) |
JAMA |
2002 |
| Rothman R, Baumann M |
Therapeutic and adverse actions of serotonin transporter substrates |
Pharmacol Ther |
2002 |
| Greene SL, Dargan PI, O'C... |
Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy") |
Am J Emerg Med |
2003 |
| Sinclair D, Fantozzi F, Y... |
Effective use of naltrexone: What doctors and patients have not been t... |
Italian Journal of t... |
2003 |
| Marona-Lewicka D, Thisted... |
Distinct temporal phases in the behavioral pharmacology of LSD: dopami... |
Psychopharmacology (... |
2005 |
| Ott J |
Obviation of opioid withdrawal syndrome by concomitant administration ... |
J Psychoactive Drugs |
2006 |
| Gillette R |
Evolution and Function in Serotonergic Systems |
Integrative and Comp... |
2006 |
| Haney M |
Opioid Antagonism of Cannabinoid Effects: Differences between Marijuan... |
Neuropsychopharmacol... |
2007 |
| Russo EB |
History of cannabis and its preparations in saga, science, and sobriqu... |
Chem Biodivers |
2007 |
| Marona-Lewicka D, Nichols... |
Further evidence that the delayed temporal dopaminergic effects of LSD... |
Pharmacol Biochem Be... |
2007 |
| Winstock AR, Marsden J, M... |
What should be done about mephedrone? |
BMJ |
2010 |
| Nielsen VT, Høgberg LC, B... |
[Bromo-Dragonfly poisoning of 18-year-old male] |
Ugeskr Laeger |
2010 |
| Krupitsky E, Nunes EV, Li... |
Injectable extended-release naltrexone for opioid dependence: a double... |
Lancet |
2011 |
| Wasik AM, Gandy MN, McIld... |
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethampheta... |
Invest New Drugs |
2011 |
| Wood DM, Stribley V, Darg... |
Variability in the 3,4-methylenedioxymethamphetamine content of 'ecsta... |
Emerg Med J |
2011 |
| Goli V, Webster LR, Lamso... |
Effects of concurrent intravenous morphine sulfate and naltrexone hydr... |
Harm Reduct J |
2012 |
| Jimenez M, Chiuve SE, Gly... |
Alcohol consumption and risk of stroke in women |
Stroke |
2012 |
| Wasik AM, Gandy MN, McIld... |
Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethampheta... |
Invest New Drugs |
2012 |
